The global Oral Anticoagulants market was valued at US$ 14530 million in 2023 and is anticipated to reach US$ 23590 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

Oral Anticoagulants Market

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Oral Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anticoagulants.

Report Scope

The Oral Anticoagulants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Anticoagulants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Anticoagulants Market Report

Report Metric	Details
Report Name	Oral Anticoagulants Market
Accounted market size in 2023	US$ 14530 million
Forecasted market size in 2030	US$ 23590 million
CAGR	7.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Direct Thrombin Inhibitors Direct Factor Xa Inhibitors
Segment by Application	Deep Vein Thrombosis (DVT) Pulmonary Embolism Acute Coronary Syndrome Hemodialysis Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Daiichi Sankyo, Armatheon, Aspen, AstraZeneca, Bayer, Cellceutix, Cosmo Pharmaceuticals, CSL Behring, Eisai, GSK, Marathon Pharmaceuticals, Ockham Biotech, Perosphere
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Anticoagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Anticoagulants Market growing?

Ans: The Oral Anticoagulants Market witnessing a CAGR of 7.1% during the forecast period 2024-2030.

What is the Oral Anticoagulants Market size in 2030?

Ans: The Oral Anticoagulants Market size in 2030 will be US$ 23590 million.

Who are the main players in the Oral Anticoagulants Market report?

Ans: The main players in the Oral Anticoagulants Market are Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Daiichi Sankyo, Armatheon, Aspen, AstraZeneca, Bayer, Cellceutix, Cosmo Pharmaceuticals, CSL Behring, Eisai, GSK, Marathon Pharmaceuticals, Ockham Biotech, Perosphere

What are the Application segmentation covered in the Oral Anticoagulants Market report?

Ans: The Applications covered in the Oral Anticoagulants Market report are Deep Vein Thrombosis (DVT), Pulmonary Embolism, Acute Coronary Syndrome, Hemodialysis, Others

What are the Type segmentation covered in the Oral Anticoagulants Market report?

Ans: The Types covered in the Oral Anticoagulants Market report are Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors

1 Oral Anticoagulants Market Overview

1.1 Product Overview and Scope of Oral Anticoagulants

1.2 Oral Anticoagulants Segment by Type

1.2.1 Global Oral Anticoagulants Market Value Comparison by Type (2024-2030)

1.2.2 Direct Thrombin Inhibitors

1.2.3 Direct Factor Xa Inhibitors

1.3 Oral Anticoagulants Segment by Application

1.3.1 Global Oral Anticoagulants Market Value by Application: (2024-2030)

1.3.2 Deep Vein Thrombosis (DVT)

1.3.3 Pulmonary Embolism

1.3.4 Acute Coronary Syndrome

1.3.5 Hemodialysis

1.3.6 Others

1.4 Global Oral Anticoagulants Market Size Estimates and Forecasts

1.4.1 Global Oral Anticoagulants Revenue 2019-2030

1.4.2 Global Oral Anticoagulants Sales 2019-2030

1.4.3 Global Oral Anticoagulants Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Oral Anticoagulants Market Competition by Manufacturers

2.1 Global Oral Anticoagulants Sales Market Share by Manufacturers (2019-2024)

2.2 Global Oral Anticoagulants Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Oral Anticoagulants Average Price by Manufacturers (2019-2024)

2.4 Global Oral Anticoagulants Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Anticoagulants, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Anticoagulants, Product Type & Application

2.7 Oral Anticoagulants Market Competitive Situation and Trends

2.7.1 Oral Anticoagulants Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Oral Anticoagulants Players Market Share by Revenue

2.7.3 Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Anticoagulants Retrospective Market Scenario by Region

3.1 Global Oral Anticoagulants Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Oral Anticoagulants Global Oral Anticoagulants Sales by Region: 2019-2030

3.2.1 Global Oral Anticoagulants Sales by Region: 2019-2024

3.2.2 Global Oral Anticoagulants Sales by Region: 2025-2030

3.3 Global Oral Anticoagulants Global Oral Anticoagulants Revenue by Region: 2019-2030

3.3.1 Global Oral Anticoagulants Revenue by Region: 2019-2024

3.3.2 Global Oral Anticoagulants Revenue by Region: 2025-2030

3.4 North America Oral Anticoagulants Market Facts & Figures by Country

3.4.1 North America Oral Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Oral Anticoagulants Sales by Country (2019-2030)

3.4.3 North America Oral Anticoagulants Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oral Anticoagulants Market Facts & Figures by Country

3.5.1 Europe Oral Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Oral Anticoagulants Sales by Country (2019-2030)

3.5.3 Europe Oral Anticoagulants Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Anticoagulants Market Facts & Figures by Country

3.6.1 Asia Pacific Oral Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Oral Anticoagulants Sales by Country (2019-2030)

3.6.3 Asia Pacific Oral Anticoagulants Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oral Anticoagulants Market Facts & Figures by Country

3.7.1 Latin America Oral Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Oral Anticoagulants Sales by Country (2019-2030)

3.7.3 Latin America Oral Anticoagulants Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Anticoagulants Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Oral Anticoagulants Sales by Country (2019-2030)

3.8.3 Middle East and Africa Oral Anticoagulants Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Anticoagulants Sales by Type (2019-2030)

4.1.1 Global Oral Anticoagulants Sales by Type (2019-2024)

4.1.2 Global Oral Anticoagulants Sales by Type (2025-2030)

4.1.3 Global Oral Anticoagulants Sales Market Share by Type (2019-2030)

4.2 Global Oral Anticoagulants Revenue by Type (2019-2030)

4.2.1 Global Oral Anticoagulants Revenue by Type (2019-2024)

4.2.2 Global Oral Anticoagulants Revenue by Type (2025-2030)

4.2.3 Global Oral Anticoagulants Revenue Market Share by Type (2019-2030)

4.3 Global Oral Anticoagulants Price by Type (2019-2030)

5 Segment by Application

5.1 Global Oral Anticoagulants Sales by Application (2019-2030)

5.1.1 Global Oral Anticoagulants Sales by Application (2019-2024)

5.1.2 Global Oral Anticoagulants Sales by Application (2025-2030)

5.1.3 Global Oral Anticoagulants Sales Market Share by Application (2019-2030)

5.2 Global Oral Anticoagulants Revenue by Application (2019-2030)

5.2.1 Global Oral Anticoagulants Revenue by Application (2019-2024)

5.2.2 Global Oral Anticoagulants Revenue by Application (2025-2030)

5.2.3 Global Oral Anticoagulants Revenue Market Share by Application (2019-2030)

5.3 Global Oral Anticoagulants Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Corporation Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Johnson & Johnson Oral Anticoagulants Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Bristol-Myers Squibb

6.2.1 Bristol-Myers Squibb Corporation Information

6.2.2 Bristol-Myers Squibb Description and Business Overview

6.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bristol-Myers Squibb Oral Anticoagulants Product Portfolio

6.2.5 Bristol-Myers Squibb Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Boehringer Ingelheim Oral Anticoagulants Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Corporation Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Oral Anticoagulants Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Daiichi Sankyo

6.5.1 Daiichi Sankyo Corporation Information

6.5.2 Daiichi Sankyo Description and Business Overview

6.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Daiichi Sankyo Oral Anticoagulants Product Portfolio

6.5.5 Daiichi Sankyo Recent Developments/Updates

6.6 Armatheon

6.6.1 Armatheon Corporation Information

6.6.2 Armatheon Description and Business Overview

6.6.3 Armatheon Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Armatheon Oral Anticoagulants Product Portfolio

6.6.5 Armatheon Recent Developments/Updates

6.7 Aspen

6.6.1 Aspen Corporation Information

6.6.2 Aspen Description and Business Overview

6.6.3 Aspen Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Aspen Oral Anticoagulants Product Portfolio

6.7.5 Aspen Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Corporation Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.8.4 AstraZeneca Oral Anticoagulants Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

6.9 Bayer

6.9.1 Bayer Corporation Information

6.9.2 Bayer Description and Business Overview

6.9.3 Bayer Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Bayer Oral Anticoagulants Product Portfolio

6.9.5 Bayer Recent Developments/Updates

6.10 Cellceutix

6.10.1 Cellceutix Corporation Information

6.10.2 Cellceutix Description and Business Overview

6.10.3 Cellceutix Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Cellceutix Oral Anticoagulants Product Portfolio

6.10.5 Cellceutix Recent Developments/Updates

6.11 Cosmo Pharmaceuticals

6.11.1 Cosmo Pharmaceuticals Corporation Information

6.11.2 Cosmo Pharmaceuticals Oral Anticoagulants Description and Business Overview

6.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio

6.11.5 Cosmo Pharmaceuticals Recent Developments/Updates

6.12 CSL Behring

6.12.1 CSL Behring Corporation Information

6.12.2 CSL Behring Oral Anticoagulants Description and Business Overview

6.12.3 CSL Behring Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.12.4 CSL Behring Oral Anticoagulants Product Portfolio

6.12.5 CSL Behring Recent Developments/Updates

6.13 Eisai

6.13.1 Eisai Corporation Information

6.13.2 Eisai Oral Anticoagulants Description and Business Overview

6.13.3 Eisai Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Eisai Oral Anticoagulants Product Portfolio

6.13.5 Eisai Recent Developments/Updates

6.14 GSK

6.14.1 GSK Corporation Information

6.14.2 GSK Oral Anticoagulants Description and Business Overview

6.14.3 GSK Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.14.4 GSK Oral Anticoagulants Product Portfolio

6.14.5 GSK Recent Developments/Updates

6.15 Marathon Pharmaceuticals

6.15.1 Marathon Pharmaceuticals Corporation Information

6.15.2 Marathon Pharmaceuticals Oral Anticoagulants Description and Business Overview

6.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio

6.15.5 Marathon Pharmaceuticals Recent Developments/Updates

6.16 Ockham Biotech

6.16.1 Ockham Biotech Corporation Information

6.16.2 Ockham Biotech Oral Anticoagulants Description and Business Overview

6.16.3 Ockham Biotech Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Ockham Biotech Oral Anticoagulants Product Portfolio

6.16.5 Ockham Biotech Recent Developments/Updates

6.17 Perosphere

6.17.1 Perosphere Corporation Information

6.17.2 Perosphere Oral Anticoagulants Description and Business Overview

6.17.3 Perosphere Oral Anticoagulants Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Perosphere Oral Anticoagulants Product Portfolio

6.17.5 Perosphere Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Anticoagulants Industry Chain Analysis

7.2 Oral Anticoagulants Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Anticoagulants Production Mode & Process

7.4 Oral Anticoagulants Sales and Marketing

7.4.1 Oral Anticoagulants Sales Channels

7.4.2 Oral Anticoagulants Distributors

7.5 Oral Anticoagulants Customers

8 Oral Anticoagulants Market Dynamics

8.1 Oral Anticoagulants Industry Trends

8.2 Oral Anticoagulants Market Drivers

8.3 Oral Anticoagulants Market Challenges

8.4 Oral Anticoagulants Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Cosmo Pharmaceuticals

CSL Behring

Eisai Co Ltd

GSK

Marathon Pharmaceuticals

Ockham Biotech

Perosphere

List of Tables

Table 1. Global Oral Anticoagulants Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Oral Anticoagulants Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Oral Anticoagulants Market Competitive Situation by Manufacturers in 2023

Table 4. Global Oral Anticoagulants Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Oral Anticoagulants Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Oral Anticoagulants Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Oral Anticoagulants Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Oral Anticoagulants Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Oral Anticoagulants, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Anticoagulants, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Anticoagulants, Product Type & Application

Table 12. Global Key Manufacturers of Oral Anticoagulants, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulants as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Anticoagulants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Oral Anticoagulants Sales by Region (2019-2024) & (K Units)

Table 18. Global Oral Anticoagulants Sales Market Share by Region (2019-2024)

Table 19. Global Oral Anticoagulants Sales by Region (2025-2030) & (K Units)

Table 20. Global Oral Anticoagulants Sales Market Share by Region (2025-2030)

Table 21. Global Oral Anticoagulants Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Oral Anticoagulants Revenue Market Share by Region (2019-2024)

Table 23. Global Oral Anticoagulants Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Oral Anticoagulants Revenue Market Share by Region (2025-2030)

Table 25. North America Oral Anticoagulants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Oral Anticoagulants Sales by Country (2019-2024) & (K Units)

Table 27. North America Oral Anticoagulants Sales by Country (2025-2030) & (K Units)

Table 28. North America Oral Anticoagulants Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Oral Anticoagulants Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Oral Anticoagulants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Oral Anticoagulants Sales by Country (2019-2024) & (K Units)

Table 32. Europe Oral Anticoagulants Sales by Country (2025-2030) & (K Units)

Table 33. Europe Oral Anticoagulants Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Oral Anticoagulants Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Oral Anticoagulants Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Oral Anticoagulants Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Oral Anticoagulants Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Oral Anticoagulants Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Oral Anticoagulants Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Oral Anticoagulants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Oral Anticoagulants Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Oral Anticoagulants Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Oral Anticoagulants Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oral Anticoagulants Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Oral Anticoagulants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Oral Anticoagulants Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Oral Anticoagulants Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Oral Anticoagulants Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Oral Anticoagulants Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Oral Anticoagulants Sales (K Units) by Type (2019-2024)

Table 51. Global Oral Anticoagulants Sales (K Units) by Type (2025-2030)

Table 52. Global Oral Anticoagulants Sales Market Share by Type (2019-2024)

Table 53. Global Oral Anticoagulants Sales Market Share by Type (2025-2030)

Table 54. Global Oral Anticoagulants Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Oral Anticoagulants Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Oral Anticoagulants Revenue Market Share by Type (2019-2024)

Table 57. Global Oral Anticoagulants Revenue Market Share by Type (2025-2030)

Table 58. Global Oral Anticoagulants Price (USD/Unit) by Type (2019-2024)

Table 59. Global Oral Anticoagulants Price (USD/Unit) by Type (2025-2030)

Table 60. Global Oral Anticoagulants Sales (K Units) by Application (2019-2024)

Table 61. Global Oral Anticoagulants Sales (K Units) by Application (2025-2030)

Table 62. Global Oral Anticoagulants Sales Market Share by Application (2019-2024)

Table 63. Global Oral Anticoagulants Sales Market Share by Application (2025-2030)

Table 64. Global Oral Anticoagulants Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Oral Anticoagulants Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Oral Anticoagulants Revenue Market Share by Application (2019-2024)

Table 67. Global Oral Anticoagulants Revenue Market Share by Application (2025-2030)

Table 68. Global Oral Anticoagulants Price (USD/Unit) by Application (2019-2024)

Table 69. Global Oral Anticoagulants Price (USD/Unit) by Application (2025-2030)

Table 70. Johnson & Johnson Corporation Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Johnson & Johnson Oral Anticoagulants Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Bristol-Myers Squibb Corporation Information

Table 76. Bristol-Myers Squibb Description and Business Overview

Table 77. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Bristol-Myers Squibb Oral Anticoagulants Product

Table 79. Bristol-Myers Squibb Recent Developments/Updates

Table 80. Boehringer Ingelheim Corporation Information

Table 81. Boehringer Ingelheim Description and Business Overview

Table 82. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Boehringer Ingelheim Oral Anticoagulants Product

Table 84. Boehringer Ingelheim Recent Developments/Updates

Table 85. Sanofi Corporation Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Sanofi Oral Anticoagulants Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Daiichi Sankyo Corporation Information

Table 91. Daiichi Sankyo Description and Business Overview

Table 92. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Daiichi Sankyo Oral Anticoagulants Product

Table 94. Daiichi Sankyo Recent Developments/Updates

Table 95. Armatheon Corporation Information

Table 96. Armatheon Description and Business Overview

Table 97. Armatheon Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Armatheon Oral Anticoagulants Product

Table 99. Armatheon Recent Developments/Updates

Table 100. Aspen Corporation Information

Table 101. Aspen Description and Business Overview

Table 102. Aspen Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Aspen Oral Anticoagulants Product

Table 104. Aspen Recent Developments/Updates

Table 105. AstraZeneca Corporation Information

Table 106. AstraZeneca Description and Business Overview

Table 107. AstraZeneca Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. AstraZeneca Oral Anticoagulants Product

Table 109. AstraZeneca Recent Developments/Updates

Table 110. Bayer Corporation Information

Table 111. Bayer Description and Business Overview

Table 112. Bayer Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Bayer Oral Anticoagulants Product

Table 114. Bayer Recent Developments/Updates

Table 115. Cellceutix Corporation Information

Table 116. Cellceutix Description and Business Overview

Table 117. Cellceutix Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Cellceutix Oral Anticoagulants Product

Table 119. Cellceutix Recent Developments/Updates

Table 120. Cosmo Pharmaceuticals Corporation Information

Table 121. Cosmo Pharmaceuticals Description and Business Overview

Table 122. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Cosmo Pharmaceuticals Oral Anticoagulants Product

Table 124. Cosmo Pharmaceuticals Recent Developments/Updates

Table 125. CSL Behring Corporation Information

Table 126. CSL Behring Description and Business Overview

Table 127. CSL Behring Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. CSL Behring Oral Anticoagulants Product

Table 129. CSL Behring Recent Developments/Updates

Table 130. Eisai Corporation Information

Table 131. Eisai Description and Business Overview

Table 132. Eisai Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Eisai Oral Anticoagulants Product

Table 134. Eisai Recent Developments/Updates

Table 135. GSK Corporation Information

Table 136. GSK Description and Business Overview

Table 137. GSK Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. GSK Oral Anticoagulants Product

Table 139. GSK Recent Developments/Updates

Table 140. Marathon Pharmaceuticals Corporation Information

Table 141. Marathon Pharmaceuticals Description and Business Overview

Table 142. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Marathon Pharmaceuticals Oral Anticoagulants Product

Table 144. Marathon Pharmaceuticals Recent Developments/Updates

Table 145. Ockham Biotech Corporation Information

Table 146. Ockham Biotech Description and Business Overview

Table 147. Ockham Biotech Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. Ockham Biotech Oral Anticoagulants Product

Table 149. Ockham Biotech Recent Developments/Updates

Table 150. Perosphere Corporation Information

Table 151. Perosphere Description and Business Overview

Table 152. Perosphere Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 153. Perosphere Oral Anticoagulants Product

Table 154. Perosphere Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Oral Anticoagulants Distributors List

Table 158. Oral Anticoagulants Customers List

Table 159. Oral Anticoagulants Market Trends

Table 160. Oral Anticoagulants Market Drivers

Table 161. Oral Anticoagulants Market Challenges

Table 162. Oral Anticoagulants Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Oral Anticoagulants

Figure 2. Global Oral Anticoagulants Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Oral Anticoagulants Market Share by Type in 2023 & 2030

Figure 4. Direct Thrombin Inhibitors Product Picture

Figure 5. Direct Factor Xa Inhibitors Product Picture

Figure 6. Global Oral Anticoagulants Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Oral Anticoagulants Market Share by Application in 2023 & 2030

Figure 8. Deep Vein Thrombosis (DVT)

Figure 9. Pulmonary Embolism

Figure 10. Acute Coronary Syndrome

Figure 11. Hemodialysis

Figure 12. Others

Figure 13. Global Oral Anticoagulants Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Oral Anticoagulants Market Size (2019-2030) & (US$ Million)

Figure 15. Global Oral Anticoagulants Sales (2019-2030) & (K Units)

Figure 16. Global Oral Anticoagulants Average Price (USD/Unit) & (2019-2030)

Figure 17. Oral Anticoagulants Report Years Considered

Figure 18. Oral Anticoagulants Sales Share by Manufacturers in 2023

Figure 19. Global Oral Anticoagulants Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Oral Anticoagulants Players: Market Share by Revenue in 2023

Figure 21. Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Oral Anticoagulants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Oral Anticoagulants Sales Market Share by Country (2019-2030)

Figure 24. North America Oral Anticoagulants Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Oral Anticoagulants Sales Market Share by Country (2019-2030)

Figure 28. Europe Oral Anticoagulants Revenue Market Share by Country (2019-2030)

Figure 29. Germany Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Oral Anticoagulants Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Oral Anticoagulants Revenue Market Share by Region (2019-2030)

Figure 36. China Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Oral Anticoagulants Sales Market Share by Country (2019-2030)

Figure 47. Latin America Oral Anticoagulants Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Oral Anticoagulants Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Oral Anticoagulants Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Oral Anticoagulants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Oral Anticoagulants by Type (2019-2030)

Figure 57. Global Revenue Market Share of Oral Anticoagulants by Type (2019-2030)

Figure 58. Global Oral Anticoagulants Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Oral Anticoagulants by Application (2019-2030)

Figure 60. Global Revenue Market Share of Oral Anticoagulants by Application (2019-2030)

Figure 61. Global Oral Anticoagulants Price (USD/Unit) by Application (2019-2030)

Figure 62. Oral Anticoagulants Value Chain

Figure 63. Oral Anticoagulants Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions